Single Source: Resource Center for the Support for Research Excellence (SuRE) Program
Forecast
National Institutes of Health plans to offer grants to colleges and universities. It is a forecast: the notice is expected around March 25, 2027, with applications due around May 25, 2027.
From the official notice on Grants.gov, last changed July 22, 2026. Checked October 31, 2026.
- Award ceilingnot stated
- Award floornot stated
- Expected awardsnot stated
- Total fundingnot stated
- Cost sharingNot required
- Funding typeGrant
Key dates
| Forecast posted | May 27, 2026 |
|---|---|
| Expected posting | March 25, 2027 |
| Expected deadline | May 25, 2027 |
| Expected award date | August 1, 2028 |
Add the deadline to your calendar
Who can apply
This opportunity is open to colleges and universities.
- Public and State controlled institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
This is a non-competitive funding opportunity intended to fund a single award. Through this single source, Notice of Funding Opportunity (NOFO), the National Institute of General Medical Sciences solicits an application to fund a single award to the current recipient of the Sure Resource Center.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The Support for Research Excellence (SuRE) program aims to develop and sustain research excellence at resource-limited institutions, many of which disproportionately serve regions of the U.S. that have not historically participated in substantial NIH research, by supporting investigator-initiated research with strong student participation. A SuRE Resource Center has been established to enhance the administrative research infrastructure of SuRE-eligible institutions and to provide services to advise investigators who are interested in applying for a SuRE award. Specifically, the Resource Center: (1) assists institutions with building research capacity, (2) conducts outreach and training to professional staff and faculty at eligible institutions, and (3) collects and reports data relevant to the goals of the program. This is a Forecast for a Single Source that will invite an application from an eligible organization to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application will be peer-reviewed, and only a meritorious application will be considered.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to NIGMS SuRE, NIGMSSuRE@nih.gov, Please contact via e-mail..
Questions people ask
Who can apply for Single Source: Resource Center for the Support for Research Excellence (SuRE) Program?
National Institutes of Health accepts applications from colleges and universities. The notice adds further conditions, so read its eligibility section.
What is the deadline for Single Source: Resource Center for the Support for Research Excellence (SuRE) Program?
Expected deadline May 25, 2027. Confirm the date and time in the official notice on Grants.gov.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience